Drug profile · INN
trisulfapyrimidines (sulfadiazine
TRIPLE SULFA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trisulfapyrimidines (sulfadiazine (TRIPLE SULFA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN trisulfapyrimidines (sulfadiazine
Brand TRIPLE SULFA
Route ORAL
Formulation SUSPENSION
Frequently asked questions
What is trisulfapyrimidines (sulfadiazine?
trisulfapyrimidines (sulfadiazine (TRIPLE SULFA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trisulfapyrimidines (sulfadiazine?
TRIPLE SULFA is a marketed brand name for trisulfapyrimidines (sulfadiazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trisulfapyrimidines (sulfadiazine?
trisulfapyrimidines (sulfadiazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.